CFS Investment Advisory Services’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-11,460
Closed -$278K – 299
2024
Q3
$278K Sell
11,460
-942
-8% -$22.7K 0.02% 258
2024
Q2
$295K Sell
12,402
-6,426
-34% -$153K 0.02% 219
2024
Q1
$449K Sell
18,828
-3,021
-14% -$72K 0.08% 114
2023
Q4
$522K Sell
21,849
-3,367
-13% -$79.1K 0.09% 101
2023
Q3
$588K Sell
25,216
-11,699
-32% -$274K 0.09% 110
2023
Q2
$866K Sell
36,915
-2,907
-7% -$68.7K 0.11% 127
2023
Q1
$945K Buy
39,822
+4,735
+13% +$111K 0.17% 72
2022
Q4
$819K Buy
35,087
+7,143
+26% +$166K 0.19% 70
2022
Q3
$646K Buy
27,944
+4,974
+22% +$118K 0.17% 65
2022
Q2
$546K Buy
+22,970
New +$552K 0.08% 159
2021
Q4
$631K Buy
+24,631
New +$645K 0.08% 154

Other funds holding IBDR

CFS Investment Advisory Services's IBDR Position: Q4 2024 in Review

CFS Investment Advisory Services sold out of iShares iBonds Dec 2026 Term Corporate ETF (IBDR) in Q4 2024, closing a stake of 11,460 shares — an estimated $278K sold.

CFS Investment Advisory Services first reported a position in IBDR in Q4 2021 and held it in 11 quarters. The position peaked at $945K in Q1 2023. 368 funds tracked by Wall St. Rank hold IBDR as of Q4 2024.

  • CFS Investment Advisory Services reported no remaining iShares iBonds Dec 2026 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
  • CFS Investment Advisory Services sold 11,460 iShares iBonds Dec 2026 Term Corporate ETF shares in Q4 2024, an estimated $278K.
  • CFS Investment Advisory Services first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2021 and held it in 11 quarters.
  • CFS Investment Advisory Services's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $945K in Q1 2023.
  • 368 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q4 2024.

Based on CFS Investment Advisory Services's 13F filing for Q4 2024, filed 21 Jan 2025.